ArticleFrontiers in immunology2022

Case report: The MSI-L/p-MMR metastatic rectal cancer patient who failed systemic therapy responds to anti-PD-1 immunotherapy after stereotactic body radiation-therapy.

Shijin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.